Comanche Biopharma Funding: $75M Raised, Series B (2024)
Comanche Biopharma is a Biotech company based in Concord, MA. It has raised $75M in total funding. Latest round: Series B.
Comanche Biopharma funding overview
Comanche Biopharma is a Biotech company based in Concord, MA. Comanche Biopharma has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2024. The round record for Comanche Biopharma runs through 2024; nothing later has been disclosed. Investors on record include New Enterprise Associates, Atlas Venture, GV (Google Ventures), F-Prime Capital, Lilly Asia Ventures, Longview Healthcare Ventures and 5 others. 11 distinct backers are named across the disclosed rounds.
Comanche Biopharma at a glance
Total raised
$75M
Latest round
Series B
Latest round date
January 2024
Industry
Biotech
Headquarters
Concord, MA
Notable investors
New Enterprise Associates, Atlas Venture, GV (Google Ventures), F-Prime Capital, Lilly Asia Ventures, Longview Healthcare Ventures, 8VC, ARCH Venture Partners
Frequently asked about Comanche Biopharma funding
How much has Comanche Biopharma raised?
Comanche Biopharma has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Comanche Biopharma?
New Enterprise Associates, Atlas Venture, GV (Google Ventures), F-Prime Capital, Lilly Asia Ventures, Longview Healthcare Ventures are named among the investors backing Comanche Biopharma.
What was the latest Comanche Biopharma funding round?
The most recent disclosed round is a Series B, announced in January 2024.
Where is Comanche Biopharma based?
Comanche Biopharma is based in Concord, MA.
What sector does Comanche Biopharma operate in?
Comanche Biopharma is tracked under Biotech from Concord, MA, with $75M in disclosed funding.
When did Comanche Biopharma last raise?
The last disclosed Comanche Biopharma round closed in January 2024 at Series B.
Comanche Biopharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Concord below to benchmark round size and investor mix.
